A Trial Comparing Nonacog Beta Pegol (N9-GP) and ALPROLIX® in Patients With Haemophilia B

Clinical trial NCT03075670 · COMPLETED

Trial details

NCT number: NCT03075670
Sponsor: Novo Nordisk A/S
Status: COMPLETED
Phase: Phase 1
Study type: INTERVENTIONAL

Congenital Bleeding Disorder Haemophilia B

Start date: 2017-03-07
Primary completion: 2017-12-08
Enrollment: 15

View on ClinicalTrials.gov

Track trials programmatically

Sponsors, conditions and status changes through the Atlas API.